Duan Yongping’s Biogen BIIB Stock Holding History

Duan Yongping’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$3.16M	–	16
2020 Q1	$3.16M	Buy	+10,000	New	+$3.03M	0.11%	13

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Duan Yongping's BIIB Position: Q2 2020 in Review

Duan Yongping sold out of Biogen (BIIB) in Q2 2020, closing a stake of 10,000 shares — an estimated $3.16M sold.

Duan Yongping first reported a position in BIIB in Q1 2020 and held it in 1 quarter. The position peaked at $3.16M in Q1 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Duan Yongping reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
Duan Yongping sold 10,000 Biogen shares in Q2 2020, an estimated $3.16M.
Duan Yongping first reported a position in Biogen in Q1 2020 and held it in 1 quarter.
Duan Yongping's Biogen position peaked at $3.16M in Q1 2020.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on H&H International Investment's 13F filing for Q2 2020, filed 11 Aug 2020.